A carregar...

Priming of pancreatic cancer cells with bispecific antibody armed activated T cells sensitizes tumors for enhanced chemoresponsiveness

In this study, we investigated the ability of bispecific antibody armed activated T cells to target drug resistant pancreatic cancer cells and whether or not “priming” these resistant cancer cells with bispecific antibody armed activated T cells could enhance subsequent responsiveness to chemotherap...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncoimmunology
Main Authors: Thakur, Archana, Ung, Johnson, Tomaszewski, Elyse N., Schienschang, Amy, LaBrie, Timothy M., Schalk, Dana L., Lum, Lawrence G.
Formato: Artigo
Idioma:Inglês
Publicado em: Taylor & Francis 2021
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8172155/
https://ncbi.nlm.nih.gov/pubmed/34123574
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2021.1930883
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!